Results 381 to 390 of about 5,633,974 (393)

Angiotensin‐converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build‐up phase

Clinical and Experimental Allergy, 2014
J. Stoevesandt, J. Hain, I. Stolze, A. Kerstan, A. Trautmann   +4 more
semanticscholar   +1 more source

The importance of catalytic promiscuity for enzyme design and evolution

Nature Reviews Chemistry, 2019
Reuben B Leveson-Gower, Clemens Mayer, Gerard Roelfes   +2 more
exaly  

Boronic acid-based enzyme inhibitors: a review of recent progress.

Current Medicinal Chemistry, 2014
H. Fu, Hao Fang, Jie Sun, H. Wang, A. Liu, J. Sun, Z. Wu   +6 more
semanticscholar   +1 more source

The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA

Nature, 2016
Ines Fonfara, Anaïs Le Rhun, Emmanuelle Charpentier   +2 more
exaly  

Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels

Chemical Society Reviews, 2012
Jinming Hu, , Shiyong Liu
exaly  

Enzyme Inhibitors.

Annals of Internal Medicine, 1981
openaire   +1 more source

Progress in enzyme immobilization in ordered mesoporous materials and related applications

Chemical Society Reviews, 2013
Martin Hartmann
exaly  

Angioedema induced by angiotensin-converting enzyme inhibitors

Current Opinion in Allergy and Clinical Immunology, 2013
P. Campo, T. Fernandez, G. Cantó, C. Mayorga   +3 more
semanticscholar   +1 more source

Angiotensin-converting enzyme inhibitors

Journal of the American Academy of Dermatology, 1994
openaire   +2 more sources

Specific Irreversible Enzyme Inhibitors

Annual Review of Pharmacology, 1970
openaire   +2 more sources